Sponsor Pipeline

JW Pharmaceutical Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
6
Recruiting
2
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 4
2
Phase 3
2
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07442006 Glycemic Variability of Combination Therapies in T2DM Type 2 Diabetes Mellitus (T2DM) Recruiting
NCT07442630 Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With… Hypercholesterolemia Active, Not Recruiting
Phase 3
NCT06643130 Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With… Hypertension Recruiting
NCT07378098 to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and… Menorrhagia Recruiting
Phase 1
NCT06703710 To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy… Healthy Recruiting
NCT07514780 To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy… Healthy Recruiting
Not specified
NCT07523971 Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic… Dyslipidemias Recruiting
Disease Areas
Get alerts when JW Pharmaceutical's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free